谭重庆，男，1981年出生，中共党员，中南大学湘雅二医院。

专业技术职务：副主任药师

主要研究方向：药物经济学

个人成果：

1、科研项目

主持：基于MPA构建PGx干预胃癌诊治的药物经济学评价模型，国家自然科学基金，编号: 81603081,2017.01-2019.12。

主持：基于MPA构建肿瘤个体化医学研究的药物经济学预测模型，湖南省科技厅重点研发计划，编号:2016JC2062，2016.08-2019.08。

2、业务水平(论文、专利、科研获奖、专著教材等)

论文: [1] Tan Chongqing, Peng Liubao*, Zeng Xiaohui, Li Jianhe, Wan Xiaomin. Chen Gannong,Wang Siying, Ouyang Lihui, Zhao Ziying. Cost - Utility Analysis of the Newly Recommended Adjuvant Chemotherapy for Resectable Gastric Cancer Patients in the 2011 Chinese National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Gastric Cancer.PharmacoEconomics, 2014, 32(3): 231-314 (SCI 论文，IF: 2.45 )

[2] Yingjie Zhang, Xiaohui Zeng, Hai jun Deng, Fangma, Ye Peng, Lidan Yi, Chongqing Tan*, Liubao Peng. Cost-effecti veness analysis of adding palbociclib as a second-line endocrine therapy for HR+/HER2- metastatic breast cancer from the US and Chinese perspectives. Cl inical Therapeutics, 2019, 41 (6) :1175-1185.